Operatives Management von Adnextumoren

Raumforderungen im Bereich der Adnexe stellen häufige Gründe für eine Konsultation eines Gynäkologen dar. Oftmals fällt die Einordnung der Befunde und somit die Festlegung des weiteren Vorgehens schwer. Im Folgenden werden verschiedene Tumoren im Bereich der Adnexe vorgestellt. Die entsprechenden diagnostischen und therapeutischen Strategien werden dargestellt und bieten einen Handlungsalgorithmus für den klinischen Alltag.

Schlüsselwörter

Adnextumor - Funktionelle Zyste - Dermoidzyste - Laparoskopie

• Literatur

• 1 Huang C, Hong M-K, Ding D-C. A review of ovary torsion. Tzu Chi Med J 2017; 29: 143-147
• 2 Prömpeler HJ. Abklärung eines Adnexbefundes. Gynäkologe 2007; 40: 813-832
• 3 Carcangiu ML, Kurman RJ, Carcangiu ML, Herrington CS. WHO Classification of Tumours of female reproductive Organs. 4. Aufl.. Lyon: International Agency for Research on Cancer; 2014
• 4 Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF. S3-Leitlinie Diagnostik, Therapie und Nachsorge maligner Ovarialtumoren, 2020; Langversion 4.0, 2020, AWMF-Registernummer: 032/035OL. Im Internet (Stand: 19.02.2021): https://www.awmf.org/uploads/tx_szleitlinien/032-035OLl_S3_Ovarialkarzinom_2020-04.pdf
• 5 Kaufmann M, Costa SD, Scharl A. Die Gynäkologie. 3. Aufl.. Berlin, Heidelberg: Springer; 2013
• 6 Pinotti JA, Franzin C de Marussi EF. et al. Evolution of cystic and adnexal tumors identified by echography. Int J Gynaecol Obstet 1988; 26: 109-114
• 7 Herrmann UJ. Sonographic patterns of ovarian tumors. Clin Obstet Gynecol 1993; 36: 375-383
• 8 Dodge JE, Covens AL, Lacchetti C. et al. Preoperative identification of a suspicious adnexal mass: a systematic review and meta-analysis. Gynecol Oncol 2012; 126: 157-166
• 9 Spencer JA, Ghattamaneni S. MR imaging of the sonographically indeterminate adnexal mass. Radiology 2010; 256: 677-694
• 10 Häusler S, Wöckel A, Rehn M. Diagnostik und Management von Adnexraumforderungen. Gynäkologe 2016; 49: 607-622
• 11 Gadducci A, Ferdeghini M, Prontera C. et al. The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: Relevance for differential diagnosis. Gynecol Oncol 1992; 44: 147-154
• 12 Myers ER, Bastian LA, Havrilesky LJ. et al. Management of adnexal mass. Evid Rep Technol Assess (Full Rep) 2006; 130: 1-145
• 13 Holcomb K, Vucetic Z, Miller MC. et al. Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women. Am J Obstet Gynecol 2011; 205: 358.e1-358.e6
• 14 Kim B, Park Y, Kim B. et al. Diagnostic performance of CA 125, HE4, and risk of Ovarian Malignancy Algorithm for ovarian cancer. J Clin Lab Anal 2019; 33: e22624
• 15 Aslan K, Onan MA, Yilmaz C. et al. Comparison of HE 4, CA 125, ROMA score and ultrasound score in the differential diagnosis of ovarian masses. J Gynecol Obstet Hum Reprod 2020; 49: 101713
• 16 Kumar V, Rajan S, Gupta S. et al. Diagnostic Value of Risk of Malignancy Algorithm (ROMA) in Adnexal Masses. J Obstet Gynaecol India 2020; 70: 214-219
• 17 Timmerman D, Valentin L, Bourne TH. et al. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol 2000; 16: 500-505
• 18 Timmerman D, Ameye L, Fischerova D. et al. Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group. BMJ 2010; 341: c6839
• 19 van Calster B, van Hoorde K, Valentin L. et al. Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study. BMJ 2014; 349: g5920
• 20 Nohuz E, De Simone L, Chêne G. Reliability of IOTA score and ADNEX model in the screening of ovarian malignancy in postmenopausal women. J Gynecol Obstet Hum Reprod 2019; 48: 103-107
• 21 Szubert S, Wojtowicz A, Moszynski R. et al. External validation of the IOTA ADNEX model performed by two independent gynecologic centers. Gynecol Oncol 2016; 142: 490-495
• 22 Valentin L, Hagen B, Tingulstad S, Eik-Nes S. Comparison of ‘pattern recognition’ and logistic regression models for discrimination between benign and malignant pelvic masses: a prospective cross validation. Ultrasound Obstet Gynecol 2001; 18: 357-365
• 23 Gramellini D, Fieni S, Sanapo L. et al. Diagnostic accuracy of IOTA ultrasound morphology in the hands of less experienced sonographers. Austr N Z J Obstet Gynaecol 2008; 48: 195-201
• 24 Sebajuri JMV, Magriples U, Small M. et al. Obstetrics and Gynecology Residents Can Accurately Classify Benign Ovarian Tumors Using the International Ovarian Tumor Analysis Rules. J Ultrasound Med 2020; 39: 1389-1393
• 25 Grimes DA, Jones LB, Lopez LM. et al. Oral contraceptives for functional ovarian cysts. Cochrane Database Syst Rev 2009; (02) CD006134
• 26 Osmers RG, Osmers M. et al. Maydell B von et al. Preoperative evaluation of ovarian tumors in the premenopause by transvaginosonography. Am J Obstet Gynecol 1996; 175: 428-434
• 27 Grimes DA, Jones LB, Lopez LM. et al. Oral contraceptives for functional ovarian cysts. Cochrane Database Syst Rev 2014; (04) CD006134
• 28 Kroon E, Andolf E. Diagnosis and follow-up of simple ovarian cysts detected by ultrasound in postmenopausal women. Obstet Gynecol 1995; 85: 211-214
• 29 Bailey CL, Ueland FR, Land GL. et al. The malignant potential of small cystic ovarian tumors in women over 50 years of age. Gynecol Oncol 1998; 69: 3-7
• 30 Kindermann G, Maassen V, Kuhn W. Laparoskopisches „Anoperieren“ von ovariellen Malignomen. Erfahrungen aus 127 deutschen Frauenkliniken. Geburtshilfe Frauenheilkd 1995; 55: 687-694
• 31 Marana R, Muzii L, Catalano GF. et al. Laparoscopic Excision of Adnexal Masses. J Am Assoc Gynecol Laparosc 2004; 11: 162-166
• 32 Du Bois A, Ewald-Riegler N. et al. Gregorio N de et al. Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group. Eur J Cancer 2013; 49: 1905-1914
• 33 Du Bois A, Ewald-Riegler N, Du Bois O. et al. Borderline-Tumoren des Ovars – eine systematische Übersicht. Geburtshilfe Frauenheilkd 2009; 69: 807-833
• 34 Menczer J, Chetrit A, Sadetzki S. The effect of hysterectomy on survival of patients with borderline ovarian tumors. Gynecol Oncol 2012; 125: 372-375
• 35 Trillsch F, Mahner S, Woelber L. et al. Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study. Ann Oncol 2014; 25: 1320-1327
• 36 van de Vrie R, Rutten MJ, Asseler JD. et al. Laparoscopy for diagnosing resectability of disease in women with advanced ovarian cancer. Cochrane Database Syst Rev 2019; (03) CD009786
• 37 Leitao MM, Boyd J, Hummer A. et al. Clinicopathologic analysis of early-stage sporadic ovarian carcinoma. Am J Surg Pathol 2004; 28: 147-159
• 38 Sevelda P, Dittrich C, Salzer H. Prognostic value of the rupture of the capsule in stage I epithelial ovarian carcinoma. Gynecol Oncol 1989; 35: 321-322
• 39 Dembo AJ, Davy M, Stenwig AE. et al. Prognostic factors in patients with stage I epithelial ovarian cancer. Obstet Gynecol 1990; 75: 263-273
• 40 Lim S, Lee KB, Chon SJ. et al. Is tumor size the limiting factor in a laparoscopic management for large ovarian cysts?. Arch Gynecol Obstet 2012; 286: 1227-1232
• 41 Matsuo K, Machida H, Yamagami W. et al. Intraoperative capsule rupture, postoperative chemotherapy, and survival of women with stage I epithelial ovarian cancer. Obstet Gynecol 2019; 134: 1017-1026
• 42 Kajiyama H, Suzuki S, Yoshikawa N. et al. Survival impact of capsule status in stage I ovarian mucinous carcinoma-A mulicentric retrospective study. Eur J Obstet Gynecol Reprod Biol 2019; 234: 131-136
• 43 Trimbos JB, Vergote I, Bolis G. et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 2003; 95: 113-125
• 44 Magrina JF. Laparoscopic surgery for gynecologic cancers. Clin Obstet Gynecol 2000; 43: 619-640
• 45 Kruitwagen RF, Swinkels BM, Keyser KG. et al. Incidence and effect on survival of abdominal wall metastases at trocar or puncture sites following laparoscopy or paracentesis in women with ovarian cancer. Gynecol Oncol 1996; 60: 233-237
• 46 Ataseven B, Grimm C, Harter P. et al. Prognostic impact of port-site metastasis after diagnostic laparoscopy for epithelial ovarian cancer. Ann Surg Oncol 2016; 23: 834-840